• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Experts weigh benefits, risks of Allergan-Inamed merger

National report — A proposed $3.2 billion merger of Botox-maker Allergan and breast-implant maker Inamed would ultimately benefit dermatologists, an Allergan official says.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!
Related Videos
Related Content
Cutibacterium acnes Dominates the Post-Laser Skin Microbiome
May 22nd 2025

Cutibacterium acnes Dominates the Post-Laser Skin Microbiome

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
March 26th 2022

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

Julia Zimmermann PD, PhD, Demonstrates PHLAS, A New Cold Plasma Skin Care Device
May 19th 2025

Julia Zimmermann PD, PhD, Demonstrates PHLAS, A New Cold Plasma Skin Care Device

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
March 17th 2022

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

Evidence Highlights Thiamidol’s Efficacy and Safety in Hyperpigmentation Treatment
May 16th 2025

Evidence Highlights Thiamidol’s Efficacy and Safety in Hyperpigmentation Treatment

Q&A: Laura Scott, MD, FAAD, and Sun Bum on the Road to Accessible Sun Safety
May 16th 2025

Q&A: Laura Scott, MD, FAAD, and Sun Bum on the Road to Accessible Sun Safety

© 2025 MJH Life Sciences

All rights reserved.